Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer-Reference-Cited by-同舟云学术

Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer

Published:2016-07 Issue:1 Volume:120 Page:41-47
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Zhang Pengcheng,Simon Antoine,Rigaud Bastien,Castelli Joël,Ospina Arango Juan David,Nassef Mohamed,Henry Olivier,Zhu Jian,Haigron Pascal,Li Baosheng,Shu Huazhong,De Crevoisier Renaud

Funder

INCa

ANR

Ligue Contre le Cancer

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference42 articles.

1. Cheung K-y, Brian K. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients;Kam;J Clin Oncol,2007

2. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (parsport): A phase 3 multicentre randomised controlled trial;Nutting;Lancet Oncol,2011

3. Xerostomia and quality of life after intensity-modulated radiotherapy vs. Conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial;Pow;Int J Radiat Oncol Biol Phys,2006

4. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated ct/linear accelerator system;Barker;Int J Radiat Oncol Biol Phys,2004

5. Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer;Duma;Strahlenther Onkol,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction and monitoring of adaptive radiation therapy timing using two-dimensional X-ray image-based water equivalent thickness;2024-07-18

2. Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review;Medicine;2024-06-28

3. Reducing Salivary Toxicity with Adaptive Radiotherapy (ReSTART): A Randomized Controlled Trial Comparing Conventional IMRT to Adaptive IMRT in Head and Neck Squamous Cell Carcinomas;Clinical Oncology;2024-06

4. Adaptive radiotherapy in head and neck cancer: Evaluating volumetric and dosimetric changes for enhanced treatment quality;Journal of Radiation Research and Applied Sciences;2024-06

5. Anatomical changes and dosimetric analysis of the neck region based on FBCT for nasopharyngeal carcinoma patients during radiotherapy;Journal of X-Ray Science and Technology;2024-05-28